Stochter
Profile Picture
The Investor 19 Nov 2026, 17:00
Post Image
Johnson & Johnson Begins Commercial Launch of OTTAVA Surgical Robot With First U.S. Installation

Johnson & Johnson (NYSE: JNJ) announced the first commercial installation of its OTTAVA robotic surgical system at Memorial Hermann-Texas Medical Center in Houston, marking the start of the platform’s U.S. commercial rollout.

OTTAVA received FDA De Novo authorization in July 2026 for ten general surgery procedures, including gastric bypass, gastrectomy, cholecystectomy and appendectomy. The system integrates four robotic arms into a standard-sized surgical table and is designed to reduce operating-room space constraints and streamline surgical workflows.

Memorial Hermann previously participated in the clinical program supporting OTTAVA’s regulatory authorization, giving Johnson & Johnson an experienced initial customer as it moves from development into commercial use. The company plans to expand the launch to additional selected U.S. hospitals while evaluating the platform for further indications.

The installation is strategically important for Johnson & Johnson’s MedTech business because it establishes OTTAVA as a commercial competitor in the fast-growing robotic surgery market. Near-term financial impact is likely limited during the early-access phase, but successful adoption could create a new long-term growth platform across robotic systems, instruments and digital surgical services.

Comments

No comments yet.

Ana sayfa